RazmikGhukasyanMDMBA(He/Him)

General Surgery Resident Physician

Dr. Ghukasyan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6333 Coldwater Canyon Ave APT 6
North Hollywood, CA 91606
Phone+1 818-425-2233

Fax+1 310-267-0369

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2017 - 2024
UCLA Anderson School of ManagementMBA, Business Administration, 2015 - 2017
David Geffen School of Medicine at UCLAClass of 2016

PubMed

10 citations
NAD+ depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibition.
Alexandra M. Moore, Lei Zhou, Jing Cui, Luyi Li, Nanping Wu
Proceedings of the National Academy of Sciences of the United States of America. 2021-02-23
37 citations
Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion.
Irmina A. Elliott, Amanda M. Dann, Shili Xu, Stephanie S. Kim, Evan R. Abt
Proceedings of the National Academy of Sciences of the United States of America. 2019-04-02
12 citations
STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [18F]FLT PET imaging.
Keke Liang, Evan R. Abt, Thuc Le, Arthur Cho, Amanda M. Dann
Proceedings of the National Academy of Sciences of the United States of America. 2021-09-07

Resident Research FellowPerformed basic science pre-clinical research exploring novel pharmacologic agent combinations in treated pancreatic cancer.2019 - 2021